Precipio Diagnostics

About:

Precipio Diagnostics is a cancer diagnostics reference laboratory delivering advanced diagnostics, advice and personalized medicine.

Website: http://www.precipiodx.com

Top Investors: Connecticut Innovations, Enhanced Capital Partners, Advantage Capital, Ironwood Capital, Kuzari Group

Description:

Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.

Total Funding Amount:

$3.77M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2011-01-01

Contact Email:

contact(AT)precipiodx.com

Founders:

A. Zaki Sabet, Ilan Danieli

Number of Employees:

51-100

Last Funding Date:

2024-05-06

IPO Status:

Public

Industries:

© 2025 bioDAO.ai